Podcast - Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 2

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/14/2025

Practical tips first: turn new trial data (e.g., MATTERHORN) into action for EG cancers—when to test, how to personalize, and how to sequence and manage toxicity across esophageal, gastric, and GEJ.

Podcast - Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/14/2025

Practical tips first: how to order, interpret, and act on biomarker tests to optimize EG cancer care—then the latest on HER2, PD-L1, MSI-H/MMR, CLDN18.2, FGFR2, and evolving targeted/immunotherapies.

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 3

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/14/2025

Practice real-world decisions, apply molecular profiling, and hone team-based care to improve outcomes. Free CME: Module 3 is a gamified, case-based deep dive into esophagogastric cancers.

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 2

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/14/2025

Free CME: Module 2 dives into new trial results, key biomarkers, and evolving strategies in esophagogastric cancer. Sharpen PA decision-making to deliver up-to-date, personalized care. Click to learn!

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1

Available until 8/6/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3 Health on 10/14/2025

Free CME: Get up to speed on esophagogastric cancer. Learn key biomarkers (HER2, PD-L1, MSI-H/MMR, CLDN18.2, FGFR2), testing methods, and how to pick targeted and immunotherapies. Practical, PA-focuse

Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care

Available until 8/18/2026
1.25 CME credits available
Posted by i3 Health on 10/14/2025

Free CME: ATTR-CM often hides in plain sight. Join Dr. Maurer to spot it sooner with genetic testing, refine diagnosis, and choose optimal therapies to improve outcomes. Click to level up your care!

Podcast: Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets

Available until 9/8/2026
0.75 CME credits available
Posted by i3 Health on 10/14/2025

Rare, fast-moving EP-NECs demand savvy care. Hear the latest on targeted agents, checkpoint inhibitors, and radionuclide therapy—plus team-based tactics to boost outcomes. Listen Now to this Free CME!

Increasing Detection and Improving Outcomes in Hereditary Transthyretin Amyloid Cardiomyopathy

Available until 8/12/2026
1.0 CME credit available (0.5 pharmacology)
Posted by i3 Health on 10/14/2025

ATTR-CM often hides in plain sight! Sharpen your diagnostic skills with genetic testing and learn optimal therapies to improve patient outcomes. Don't miss this FREE accredited activity!

Raising the Bar for Hemophilia Management

Available until 9/22/2026
1.5 CME credits available
Posted by i3 Health on 10/14/2025

Hemophilia care is evolving fast. Learn cutting-edge therapies (including gene therapy), early arthropathy detection, and strategies to optimize outcomes and quality of life—Start the FREE Course Now!

Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets

Available until 9/8/2026
0.75 CME credits available
Posted by i3 Health on 10/14/2025

Rare, fast-moving EP-NECs demand savvy care. Hear the latest on targeted agents, checkpoint inhibitors, and radionuclide therapy—plus team-based tactics to boost outcomes. Level up your EP-NEC skills.